Bladder cancer, known for its recurrence, may see improved treatment through a repurposed tuberculosis vaccine. The Bacillus Calmette-Guérin (BCG) vaccine has long been used against non-muscle invasive bladder cancer (NMIBC) to prevent recurrence. Researchers in Barcelona are testing a newer tuberculosis vaccine,

Foghorn Therapeutics showcases its innovative cancer treatments at the 2025 AACR Meeting. FHD-909 targets SMARCA4 mutated non-small cell lung cancer (NSCLC) with selective SMARCA2 inhibition. First-in-class strategy aims to inhibit vital proteins necessary for tumor growth, showing promise in Phase 1 trials.

Rakovina Therapeutics, based in Vancouver, is revolutionizing oncology by integrating artificial intelligence (AI) with cancer therapy precision. AI-driven advancements have led to the creation of PARP1-selective inhibitors targeting brain tumors, overcoming the blood-brain barrier challenge. Rakovina utilizes Deep Docking technology, allowing AI

Cancer Action Day in Maine unites survivors, caregivers, and volunteers to advocate for transformative cancer care legislation. The focus is on expanding biomarker testing, which enables personalized cancer treatments, and increasing tobacco taxes by $1. Sharon Dow embodies personal advocacy, fighting for

Yale scientists have discovered a lupus-related antibody that turns “cold” tumors into immune system targets, defying cancer’s evasive tactics. This antibody awakens the immune response, particularly in diseases like glioblastoma, enhancing survival possibilities without conventional therapies. Offering a novel form of gene

Hugh Fountain, a celebrated football coach from East Brewton, Alabama, left a profound impact through his dedication to sports and life lessons. His coaching career spanned decades across several schools, including Charles Henderson and W.S. Neal, emphasizing character building and leadership over

Asia is experiencing a significant economic revival, driven by transformation, ambition, and innovation. China remains a key player, thriving amid traditional industries and advanced technology, despite regulatory and geopolitical challenges. India pursues a ‘Digital India’ vision, enhancing its digital infrastructure and fostering

Bladder cancer treatment faces numerous challenges, from limited resources such as infusion chairs to socio-economic barriers affecting patient care access. Dr. Petros Grivas leads efforts to overcome these obstacles at the University of Washington Medicine and Fred Hutchinson Cancer Center. Regulatory approvals

Small-cap AI stocks are emerging as promising investment opportunities amid the dominance of larger tech firms. These companies are innovating specialized AI solutions across sectors including healthcare, finance, and cybersecurity. Between 2023 and 2024, the AI investment landscape shifted, creating new opportunities